TrialMolecular cancer2021

Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion.

Zhixiong Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.